iCAD Inc (ICAD) has released an update to notify the public and investors about its officers.
Michael John Doyle was appointed to the Board of Directors of iCAD, Inc. on January 23, 2024, and received an option to purchase 40,000 shares of the company’s common stock. He brings extensive experience to the role, having held leadership positions at various healthcare and technology companies, including Spire Health, COTA Healthcare, QPID Health, and Medsphere Systems Corporation. Mr. Doyle holds a B.S. from Tufts University and an M.B.A. from the University of Chicago’s Booth School of Business. There are no reported arrangements, family relations with other directors or officers, or disclosable transactions under Regulation S-K related to his appointment.
For further insights into ICAD corporate activity, check out TipRanks’ Insiders Trading Activity page.
